gliptin and glp-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? GLP-1/GLP-1R axis: from metabolism (obesity

The development of GLP-1-based drugs like Wegovy and Saxenda has set a new standard for obesity treatment, but the progress doesnt stop here

GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion whilst simultaneously suppressing glucagon release from alpha cells

Choose liquids without alcohol

Hims & Hers is poised for a sharp downturn in sales but may not be done yet

Lotte Bjerre Knudsen, the legendary Chief Scientific Advisor at Novo Nordisk and the driving force behind the development of semaglutide (recently recognized with the 2025 Breakthrough Prize), took the stage

Many Texas insurers cover Ozempic for diabetes management but not for weight loss alone